Dashboard
Discussions
Watchlists
Collections
Tools
More
Events
SIGN UP
SIGN IN
ENTITY
Shanghai Junshi Biosciences (1877 HK)
Watchlist
229
Analysis
Health Care
•
China
Shanghai Junshi Biosciences Co., Ltd. operates as a biopharmaceutical company. The Company develops and sells small molecule drugs, antibody drug conjugates, and other products. Shanghai Junshi Biosciences markets its products worldwide.
more
Watchlist
All
Insights
Broker
Sponsored
Syndicated
Podcast
Buy side
Refresh
Focused
Suggested
bullish
•
Shanghai Junshi Biosciences
•
16 Jan 2025 15:02
Shanghai Junshi Bioscience (1877 HK): Key Drug on High Trajectory; Geopolitical Tension Spoils Party
Shanghai Junshi Biosciences sees strong revenue growth for toripalimab in China. While US launch of the drug was in-line, geopolitical tensions...
Tina Banerjee
Follow
393 Views
Share
bearish
•
Shanghai Junshi Biosciences
•
13 Apr 2023 01:12
[Junshi Biosciences (1877 HK) TP Change]: Medium to near Term Outlook Is Still Cloudy at Best
We continue to view JUNSHI’s Phase III pipeline, consisting of Senaparib (JS109/IMP4297)(PARP), Ongericimab (JS002)(PCSK9), Bevacizumab...
Blue Lotus Research Institute
Follow
356 Views
Share
bearish
•
Shanghai Junshi Biosciences
•
07 Jul 2024 01:19
China Healthcare Weekly (July.7) - MNCs' Next Move In Licensing Deals, Topchoice, Junshi's Trouble
Investors should wait to see MNCs' next move before deciding on licensing deals. Topchoice's growth is positive but unit price per customer may...
Xinyao (Criss) Wang
Follow
458 Views
Share
bullish
•
Innovent Biologics Inc
•
03 Apr 2022 23:57
Innovent Biologics Inc (1801.HK) - Capable of Surviving “this Winter”
After continuous pullback, investors may lose interest in Innovent. However, it still has investment value based on pipeline, resources, R&D and...
Xinyao (Criss) Wang
Follow
338 Views
Share
bullish
•
Thematic (Sector/Industry)
•
26 Jan 2025 00:30
APAC Healthcare Weekly (Jan 26)- Daiichi Sankyo, Sumitomo Pharma, Fosun Pharma, SK Bioscience, Hugel
APAC healthcare companies got approvals for new products as well as clinical trials. The companies continued with acquisitions and collaborations...
Tina Banerjee
Follow
379 Views
Share
Copyright © 2022 Smartkarma Innovations Pte Ltd. All Rights Reserved. v3.49.0
x